Merck
Latest Merck News
-
News Summary: Generic Rivals Hurt Merck Results
First-quarter sales and net income for Merck & Co. both plunged — 9 percent and unusually heavy trading. THE FORECAST: Merck said it expects better results in below its February forecast. ON DECK: Merck has five drugs under review by regulators
-
Stocks Edge Lower on Manufacturing, Jobs Slowdown
policies have helped keep loan rates at record lows. Company earnings were also in the spotlight Wednesday. Drugmaker Merck & Co. fell $1.30, or 2.8 percent, to $45.70 after it cut its 2013 profit forecast. The company said competition
-
Stocks Edge Lower After Manufacturing Growth Slows
risen for five straight months and the S&P 500 for six. Company earnings were also in the spotlight Wednesday. Drugmaker Merck & Co. fell $1.30, or 2.8 percent, to $45.70 after it cut its 2013 profit forecast. The company said competition
-
Stocks Fall on Jobs Concerns, Fall in Merck Profit
S. companies added the fewest jobs in seven months and Merck reported a lower quarterly profit. Shortly after the market lost five points to 3,323, a decline of 0.2 percent. Merck led the Dow lower after the drugmaker's quarterly profit
-
Generic Competition Cuts Merck's Q1 Sales, Profit
Drugmaker Merck & Co. is reporting lower first-quarter up to $15 billion worth of its stock. Merck 's first-quarter profit fell 8.3 percent Analysts expected $11.11 billion. Merck shares fell 99 cents to $46.01 in premarket
-
Investing: Biotech funds leaders in 2012
according to Morningstar, the Chicago fund trackers. The stock is up 17.8% this year, including dividends. Similarly, Merck ( MRK ), which carries a 3.73% dividend yield, has gained 22.7%. Big pharmaceutical companies have taken a bad rap
News
-
7 Richest Snitches: Time to Rat Out Your Boss?Ever dream of getting rich by blowing the whistle on your boss? People have—most recently Bradley Birkenfeld, the ex-banker whom the IRS paid a record $104 million for ratting out his former banking bosses who had helped U.S. clients to hide money in Swiss accounts. Have any other blowers cashed in
-
Implantable Birth Control Known to Go Missing
lost, according to an article in the U.K. Daily Mail. Merck , the New Jersey-based manufacturer of Implanon, declined because the implant is not where it should be," according to Merck 's patient handout on the device. Dr. Alan Penzias
-
Health care reform winner: Hospital stocks; Loser: Insurers
results since the ruling, with J&J adding 3% and Stryker dropping 1%. Drugmakers have also been winners. Shares of Merck mrk and Pfizer pfe are up 9% and 4%. But if there's one area where the predictors were wrong it's with the health insurers
-
For Some Men, Propecia's Sexual Side Effects May Be Long-lastingless pervasive side effects. FDA, Merck Know of Drug's Side Effects Finasteride originally developed in 1992 by drug giant Merck as a treatment for enlarged prostates Administration in 1997, and at that time Merck noted that a few men reported sexual
-
Merck Panned for 'Madagascar 3' Children's Claritin CampaignThe drug company Merck is in hot water for using cartoon characters products." The complaint also accused Merck of using social media to market Claritin attorney who wrote the complaint, said Merck is making a drug look like food, noting
-
Are 'Spray-On' Tans Safe? Experts Raise Questions as Industry Puts Out Warningsprovided ABC News with a letter written by a Merck scientist in late May 2012 criticizing the study. Merck is the largest manufacturer of DHA, Levy said. In its critique of the 2004 study, a Merck toxicologist cited results of two studies
-
Propecia: FDA Warns on Baldness Drug
manufactured by pharmaceutical giant Merck and Co. The FDA reviewed 421 reports taking the drug. In a statement, Merck emphasized that it's not clear that cause continued sexual dysfunction. " Merck believes that Propecia and Proscar
Videos
-
U.S. Spending Up Despite Payroll Taxdoing kind of what they should do which is Poland and the horns a little bit. Now are pharmaceutical news this morning Merck and Pfizer joining forces to come up with a new drug to treat type two diabetes. It's a little unusual for this kind
the horns a little bit. Now are -- pharmaceutical news this morning Merck and Pfizer joining forces to come up with a new drug to treat type two diabetes. It's a little unusual for this -
Nightline 04/23: Drones: Headed for Commercial Use?made a few laps over the airstrip and and Justin brought this hockey and for a landing. Can just keep this level. Maybe Merck . They were loud just sin per facts. About working with drones isn't all about flying. With the aerial cameras and other
hockey and for a landing. Can just keep this -- level. Maybe Merck . They were loud just sin per facts. About working with drones isn't all about flying. With the aerial cameras and other sensors -
Drones: Headed for Commercial Use?made a few laps over the and then Justin brought the sky hockey and for a landing. Can just keep this week's level. New Merck . The loud just per fact. About working with drones isn't all about flying. With the aerial cameras and other sensors
hockey and for a landing. Can just keep this week's level. New Merck . The loud just -- per fact. About working with drones isn't all about flying. With the aerial cameras and other sensors -- -
Ian Somerhalder Discusses His Role On CW's The Vampire Diariesoften cut. And then we go directly in the making one another. do which face which is the Damon smirk And that's that's Merck . Has you. The person who wins all of these Even when twilight was at its peak and rob patents and was supposed to be it
do which face which is the Damon smirk -- And that's that's Merck . Has -- you. The person who wins all of these -- Even when twilight was at its peak and rob patents and -
Merck Response to ABC NewsFosamax and the other this and it's have been used in millions of women in the United States and around the world. Merck remains absolutely committed to studying the safety Fosamax. When talking there reports of potential side effects. It's
in millions of women in the United States and around the world. Merck remains absolutely committed to studying the safety Fosamax. When talking there -- reports of potential side effects. It's important to keep in -
Drug Giant Settles Suit for $670 Millionpopular drugs. Pharmaceutical giant Merck will pay 671. Million dollars. After whistle blowers including a former Merck employee. Helped make the case. Zocor arthritis. Help make the drug giant Merck billions of dollars. Today prosecutors
settlement with the government over claims involving two popular drugs. Pharmaceutical giant Merck will pay -- 671. Million dollars. After allegations it overcharged Medicaid and paid kickbacks to doctors. As ABC's Pierre Thomas reports whistle blowers including a former Merck employee. Helped make the case. Zocor a drug that lowers cholesterol -- Vioxx was used to treat the pain of arthritis. Help make the drug giant Merck billions of dollars. Today prosecutors said the company had been bilking the government of millions and bribing doctors to dominate the market. They've got to play by the rules. And the rules require that they give the government the same price they're gonna give to anybody else. Investigators claim Merck entered into secret illegal agreements with hospitals. Giving them deep discounts in exchange for dropping the drugs of competitors. But those same discounts were not passed along to the federal government's Medicaid system. Which had to pay a lot more for the drugs and that according to prosecutors. Was a violation of the law. According to the government and industry analyst some doctors who prescribed to Merck products. We're giving millions of dollars in illegal kickbacks cash and trips disguised as these. For training and consultation. Merck employee finally blew the whistle his -- says it was all part of company strategy. Drug companies that take advantage of government programs like this force people to choose between medicine and heat. Medicine and food for their families. The whistle -- -- to make more than sixty million dollars from the settlement Merck officials today admitted no wrongdoing telling ABC news. They thought they were playing by the rules. Even so it cost them more -
Baby Vaccine RecallThe drugmaker Merck is recalling the vaccine routinely given to babies the recall covers more than a million doses of the vaccine known as Kim. Which
The drugmaker Merck is recalling the vaccine routinely given to babies the recall covers more than a million doses of the vaccine known as Kim.
